Rallis India Limited submitted its unaudited financial results for Q1 FY27 (quarter ended June 30, 2026) to BSE Limited and National Stock Exchange of India Limited pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Financial Performance Q1 FY27
- Revenue: ₹1022 crore, up 7% YoY from ₹957 crore in Q1 FY26
- Profit After Tax (PAT): ₹125 crore, up 31% YoY from ₹95 crore in Q1 FY26
- EBITDA growth: 23% YoY (specific EBITDA amount not disclosed)
Business Segment Performance
Crop Care Business:
- Revenue: ₹697 crore, up 7% YoY
- B2C segment: 19% growth
- B2B segment: 19% decline
- New product launches: Balwan (Herbicide), Prodim Ultra (Herbicide), and Kengen (Insecticide)
Soil & Plant Health (SPH) Segment:
- Growth: 10% YoY
- Supported by portfolio management, pricing actions, and contribution from Biostimulants, Biofertilizers, and Organic products
- New launch: Aquafert Ginger and Turmeric
Seeds Business:
- Revenue: ₹325 crore, up 6% YoY
- Nine new product launches across Cotton, Paddy and Millet crops
- Includes two new Cotton hybrids for North India and Herbicide Tolerant Direct Seed Rice product under Dhaanya brand
Management Commentary
Dr. Gyanendra Shukla, Managing Director & CEO, stated that the resilient performance was driven by focused execution across businesses, improved profitability, and continued investments in strengthening portfolio and capabilities. The company reported disciplined pricing actions and cost optimization initiatives contributing to improved profitability. Management remains committed to delivering differentiated solutions through continued investments in innovation, customer-centricity, and operational excellence.
Corporate Background
Rallis India Limited is a subsidiary of Tata Chemicals Limited and part of the Tata Group. The company has 77 years of experience in serving rural markets with a comprehensive portfolio of agri-input products. Distribution network includes 7,200 dealers and over 95,000 retailers across India.